Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain‐Sense Study
Movement Disorders · 2025
DOI: 10.1002/mds.30160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Aaron Colombo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Subthalamic Nucleus, Gamma Rhythm. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gottfried und Julia Bangerter-Rhyner-Stiftung, Department of Neurology, Bern University Hospital, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Background
Novel commercial brain‐sense neurostimulators enable us to contextualize brain activity with symptom and medication states in real‐life ambulatory settings in Parkinson's disease (PD). Although various candidate biomarkers have been proposed for adaptive deep brain stimulation (DBS), a comprehensive comparison of their ambulatory profiles is lacking.
Objectives
To systematically compare the ambulatory neurophysiological dynamics and clinical properties of three candidate biomarkers—low‐frequency, beta (β), and finely tuned γ (FTG) activity.
Methods
We investigated 14 PD patients implanted with the Medtronic Percept PC, who underwent up to two 4‐week ambulatory multimodal recording periods on their regular medication and stimulation. Subthalamic nucleus local field potentials (LFPs) of low‐frequency, β, and FTG activity were recorded. Additionally, objective motor symptom states, physical activity and heart rate using wearables, as well as medication‐intake times, sleep‐awake times, and subjective symptom states using diaries were co‐registered. LFP dynamics were also compared to high‐resolution in‐hospital recordings under off / on dopaminergic medication and stimulation conditions.
Results
FTG reliably indexed off to on medication states in the ambulatory setting at the group and individual levels, and these spectral dynamics could be anticipated by high‐resolution in‐hospital recordings. Both FTG and low‐frequency correlated with wearable‐based dyskinesia scores, whereas diary‐based dyskinesia events were only linked to FTG. Importantly, FTG indicated on ‐medication states regardless of the presence of dyskinesia and despite potential motion and heart rate artifacts. The 24‐hour profile revealed large circadian power shifts that may overdrive medication‐intake dynamics.
Conclusion
Despite the limitations of low‐temporal resolution recordings, this work provides valuable insights into the real‐life dynamics of biomarkers. Specifically, it highlights the utility of FTG as a primary and reliable indicator of medication states for adaptive DBS. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.
- ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.
- Graduate School of Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland.
- Department of Neurosurgery, Bern University Hospital and University of Bern, Bern, Switzerland.
- Institute of Neurology, Konolfingen, Switzerland.
ORCID-Profile: Aaron Colombo, Ines Debove, T A Khoa Nguyen, Lenard Lachenmayer, Tobias Nef, Alberto Averna
Förderung
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Department of Neurology, Bern University Hospital
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Swiss Parkinson Association
- Parkinson Schweiz
- Department of Neurology, College of Medicine, Medical University of South Carolina
Zitieren
APA
Colombo, A., Bernasconi, E., Alva, L., Sousa, M., Debove, I., Nowacki, A., Serquet, C., Petermann, K., Nguyen, T. A. K., Magalhães, A. D., Lachenmayer, L., Waskönig, J., Nef, T., Schuepbach, M., Pollo, C., Krack, P., Averna, A., & Tinkhauser, G. (2025). Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain‐Sense Study. Movement Disorders. https://doi.org/10.1002/mds.30160
Vancouver
Colombo A, Bernasconi E, Alva L, Sousa M, Debove I, Nowacki A, et al. Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain‐Sense Study. Movement Disorders. 2025. doi:10.1002/mds.30160
BibTeX
@article{Colombo2025,
author = {Colombo, Aaron and Bernasconi, Elena and Alva, Laura and Sousa, Mario and Debove, Ines and Nowacki, Andreas and Serquet, Camille and Petermann, Katrin and Nguyen, T A Khoa and Magalhães, Andreia D and Lachenmayer, Lenard and Waskönig, Julia and Nef, Tobias and Schuepbach, Michael and Pollo, Claudio and Krack, Paul and Averna, Alberto and Tinkhauser, Gerd},
title = {Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain‐Sense Study},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.30160}
}
EUVIMED